» Articles » PMID: 10547579

Nitric Oxide Synthases in Normal and Benign Hyperplastic Human Prostate: Immunohistochemistry and Molecular Biology

Overview
Journal J Pathol
Specialty Pathology
Date 1999 Nov 5
PMID 10547579
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The expression of nitric oxide synthase (NOS) isoforms has been investigated in normal (three subjects) and benign hyperplastic prostate (ten patients) by immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR). The inducible NOS (iNOS or NOS-2) is not detected in normal prostate, while it is expressed in the prostate of all benign prostatic hyperplasia (BPH) patients, even in the absence of prostatitis or systemic signs of an inflammatory condition. This suggests that sex hormones may be involved in iNOS induction and that there may be a role for NO in the pathogenesis of BPH. Constitutive NOSs (nNOS and eNOS) are expressed in both normal and hyperplastic prostate and are co-expressed in epithelial cells. eNOS, however, is present mainly in the basal layer cells; nNOS seems abundantly expressed in the more superficial cells of the affected prostate. This indicates that the switching between the two constitutive isoforms may be part of the usual process of cell differentiation from the basal to the secretory layer of the epithelium.

Citing Articles

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives.

Kaltsas A, Giannakas T, Stavropoulos M, Kratiras Z, Chrisofos M Diseases. 2025; 13(2).

PMID: 39997060 PMC: 11854834. DOI: 10.3390/diseases13020053.


The Role of Heat Shock Protein 70 Subfamily in the Hyperplastic Prostate: From Molecular Mechanisms to Therapeutic Opportunities.

Fu X, Liu H, Liu J, DiSanto M, Zhang X Cells. 2022; 11(13).

PMID: 35805135 PMC: 9266107. DOI: 10.3390/cells11132052.


Immunomodulatory effect of diallyl sulfide on experimentally-induced benign prostate hyperplasia via the suppression of CD4+T/IL-17 and TGF-β1/ERK pathways.

Elbaz E, Amin H, Kamel A, Ibrahim S, Helmy H Inflammopharmacology. 2020; 28(5):1407-1420.

PMID: 32785828 DOI: 10.1007/s10787-020-00743-1.


Combined and Extracts (WS 1541) Exert Anti-proliferative and Anti-inflammatory Effects in a Mouse Model of Benign Prostate Hyperplasia.

Pigat N, Reyes-Gomez E, Boutillon F, Palea S, Barry Delongchamps N, Koch E Front Pharmacol. 2019; 10:311.

PMID: 30984003 PMC: 6450068. DOI: 10.3389/fphar.2019.00311.


-Nitroso--acetyl-L-cysteine ethyl ester (SNACET) and -acetyl-L-cysteine ethyl ester (NACET)-Cysteine-based drug candidates with unique pharmacological profiles for oral use as NO, HS and GSH suppliers and as antioxidants: Results and overview.

Tsikas D, Schwedhelm K, Surdacki A, Giustarini D, Rossi R, Kukoc-Modun L J Pharm Anal. 2018; 8(1):1-9.

PMID: 29568662 PMC: 5859134. DOI: 10.1016/j.jpha.2017.12.003.